Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

Ejection Fraction Analysis of FactorsCan InfluenceEjection Fraction

The relatively low rates of risk factors , the small infarct sizecould ... have influencedthe preserved ejection fraction

If EDV , or preload , is increased , the Frank - Starling mechanism will increase stroke volume such that ESV remains the sameresultingin a preserved ejection fraction

I / R injury(passive) caused byejection fraction

transverse aortic constriction and deoxycorticosterone infusion(passive) created bya preserved ejection fraction

to 33 % , 45 % , or 60 %(passive) was setEjection fraction

impaired ischemic myocardial contractility(passive) caused byejection fraction

changes in loading conditions ( higher preload , lower afterload(passive) caused byejection fraction

heart ratesettingEjection fraction

4Factorsinfluencingejection fraction

adversely(passive) was influencedEjection fraction

respiratory - induced intrathoracic pressure changes during normal free breathing(passive) caused byejection fraction

Volle(passive) Created ByPreserved Ejection Fraction ( HFpEF

an identical cardiac myosin - binding protein C gene abnormality(passive) caused bypreserved LV ejection fraction

a reduction of systolic dimensions(passive) mainly caused byejection fraction

that some pioneering trials of autologous bone marrow stem cells have unexplained discrepancies that cast doubt on their validity.5 discrepancies was not possible to report this directly in the journals that published the trials.5 Discrepancies in reports have never been systematically explored as a possible explanatory variable for the effect size of autologous bone marrow stem cells on ejection fraction(passive) has recently been discoveredejection fraction

hardening of heart muscles(passive) caused bypreserved ejection fraction

a virus(passive) caused byejection fraction

to systolic heart failureleadsto systolic heart failure

pharmacologic stress on the heartCausespharmacologic stress on the heart

a 60 to 75 percentsettinga 60 to 75 percent

from diastolic function abnormalities in patients with left ventricular outflow tract obstruction.51resultingfrom diastolic function abnormalities in patients with left ventricular outflow tract obstruction.51

ischemiacauseischemia

the risk of rehospitalization ( P=0.035influencedthe risk of rehospitalization ( P=0.035

in pulmonary edema and abnormal cardiac screening testsresultingin pulmonary edema and abnormal cardiac screening tests

independentlyinfluencedindependently

treatment discontinuation in everolimus - treated patients and one in the placebo groupcausedtreatment discontinuation in everolimus - treated patients and one in the placebo group

from reduced LV cavity sizeresultingfrom reduced LV cavity size

to episodes of arrhythmia , progressive pump failureleadingto episodes of arrhythmia , progressive pump failure

in better survival rateresultingin better survival rate

to 33 , 45 , and 60 %setto 33 , 45 , and 60 %

in substantial morbidity and mortalityresultingin substantial morbidity and mortality

the hemodynamic consequences of arrhythmias , both supraventricular and ventricularmay influencethe hemodynamic consequences of arrhythmias , both supraventricular and ventricular

to decompensation , valvular damage , or worse arrhythmias.6leadingto decompensation , valvular damage , or worse arrhythmias.6

to trastuzumab interruptionleadingto trastuzumab interruption

from therapy with nonglycosidic positive inotropic agentsresultingfrom therapy with nonglycosidic positive inotropic agents

in alcoholic cardiomyopathyresultingin alcoholic cardiomyopathy

breathing problems and swelling in the feet and legscan causebreathing problems and swelling in the feet and legs

a significant misinterpretation of the actual pathophysiologycausesa significant misinterpretation of the actual pathophysiology

to a subgroup - treatment interaction in the main SOLVD publicationsledto a subgroup - treatment interaction in the main SOLVD publications

topamaxdoes ... causetopamax

patients with symptomatic HF(passive) caused bypatients with symptomatic HF

Blob

Smart Reasoning:

C&E

See more*